Yılmaz Çapan

Lokman Hekim Üniversitesi — Turkey

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

29h-index2.9kcitations101works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Drug Delivery Systems(37), Nanoparticle-Based Drug Delivery(34), Drug Solubulity and Delivery Systems(15), RNA Interference and Gene Delivery(13), Analytical Methods in Pharmaceuticals(11)

Publications101 total

FDA original new drug approvals in the first quarter of 2025
European Journal of Life Sciences·2025Open Access
An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles
Journal of drug targeting·2024· 7 cited
Current progress in PLGA-based nanoparticles for treatment of cancer diseases
Elsevier eBooks·2023
Hybrid PLGA nanoparticles as advanced drug delivery and theranostic applications
Elsevier eBooks·2023· 3 cited
Contributors
Elsevier eBooks·2023
Structural and Functional Analysis of CEX Fractions Collected from a Novel Avastin® Biosimilar Candidate and Its Innovator: A Comparative Study
Pharmaceutics·2022· 11 citedOpen Access
pH-sensitive chitosan-PEG-decorated hollow mesoporous silica nanoparticles could be an effective treatment for acute myeloid leukemia (AML)
Journal of Nanoparticle Research·2022· 7 cited
Targeted Drug Delivery of Nanoparticles
Materials horizons·2022
Overcoming the challenges of drug resistance through combination drug delivery approach
Elsevier eBooks·2022· 3 cited
List of contributors
Elsevier eBooks·2022
PLGA-Based Nanomaterials for Cancer Therapy
Materials horizons·2022· 1 cited
Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier
Journal of Drug Delivery Science and Technology·2021· 35 cited
Regulatory Guidelines of the US Food and Drug Administration and the European Medicines Agency for Actively Targeted Nanomedicines
2021· 4 cited
Drug Delivery with Targeted Nanoparticles
2021· 9 cited
Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells
Journal of Drug Delivery Science and Technology·2021· 46 cited
Fractionated charge variants of biosimilars: A review of separation methods, structural and functional analysis
Analytica Chimica Acta·2021· 29 cited
Brain-targeted nanoparticles to overcome the blood-brain barrier
Journal of Pharmaceutical Technolgy·2020· 16 citedOpen Access
Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration
International Journal of Pharmaceutics·2020· 50 cited
Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer
Journal of Drug Delivery Science and Technology·2019· 45 cited
Development of Paclitaxel and Flurbiprofen Co-Loaded PLGA Nanoparticles: Understanding Critical Formulation and Process Parameters Using Plackett–Burman Design
Istanbul Journal of Pharmacy·2019· 4 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Turgay Dalkara(16), Seçil Çaban(11), Adem Şahin(10), Patrick Couvreur(9), Yeşim Aktaş(8), Müge Yemişçi(8), A. A. Hıncal(7), Patrick P. DeLuca(6), İmran Vural(6), Güneş Esendağlı(6), Karine Andrieux(5), Eduardo Fernández-Megía(5), Fırat Yerlikaya(5), Mansoor A. Khan(5), Hayrettin Tonbul(5), Sevda Şenel(5), Ramón Novoa-Carballal(4), Ricardo Riguera(4), Mustafa F. Sargon(4), Yasemin Özdemir(4)